Cancer cells often undergo significant metabolic reprogramming to support rapid growth and proliferation. This phenomenon is known as the Warburg effect, where cancer cells prefer glycolysis over oxidative phosphorylation, even in the presence of oxygen. This metabolic shift allows cancer cells to generate the necessary building blocks for cell growth and division. Targeting these metabolic pathways is an area of active research in cancer therapy.
